{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:32:29Z","timestamp":1791919949051,"version":"4.3.4"},"reference-count":90,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/aog.0b013e3181d41191","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T01:52:40Z","timestamp":1268790760000},"page":"839-855","source":"Crossref","is-referenced-by-count":66,"title":["Role of Hormone Therapy in the Management of Menopause"],"prefix":"10.1097","volume":"115","author":[{"given":"Jan L.","family":"Shifren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210126","article-title":"Feminine forever.","author":"Wilson","year":"1966"},{"key":"R2-25-20210126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R3-25-20210126","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.","volume":"297","author":"Rossouw","year":"2007","journal-title":"JAMA"},{"key":"R4-25-20210126","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/jama.1979.03300220017014","article-title":"Effects of estrogens on sleep and psychological state of hypogonadal women.","volume":"242","author":"Schiff","year":"1979","journal-title":"JAMA"},{"key":"R5-25-20210126","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1016\/j.amjmed.2005.09.031","article-title":"Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives.","volume":"118","author":"Woods","year":"2005","journal-title":"Am J Med"},{"key":"R6-25-20210126","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0002-9378(12)90817-0","article-title":"Impact of climacteric on well-being: a survey based on 5213 women 39 to 60 years old.","volume":"168","author":"Oldenhave","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R7-25-20210126","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/aje\/152.5.463","article-title":"Relation of demographic and lifestyle factors to symptoms in a multi-racial\/ethnic population of women 40\u201355 years of age.","volume":"152","author":"Gold","year":"2000","journal-title":"Am J Epidemiol"},{"key":"R8-25-20210126","first-page":"264","article-title":"Smoking, body mass, and hot flashes in midlife women.","volume":"101","author":"Whiteman","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R9-25-20210126","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200512020-00009","article-title":"Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters.","volume":"12","author":"Freedman","year":"2005","journal-title":"Menopause"},{"key":"R11-25-20210126","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0015-0282(01)01791-5","article-title":"Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.","volume":"75","author":"Utian","year":"2001","journal-title":"Fertil Steril"},{"key":"R12-25-20210126","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.1980.03310130021021","article-title":"Oral medroxyprogesterone in the treatment of postmenopausal symptoms.","volume":"244","author":"Schiff","year":"1980","journal-title":"JAMA"},{"key":"R13-25-20210126","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/01.AOG.0000284450.51264.31","article-title":"Lowest effective transdermal 17\u03b2-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.","volume":"110","author":"Bachmann","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R14-25-20210126","first-page":"726","article-title":"Initial 17\u03b2-estradiol dose for treating vasomotor symptoms.","volume":"95","author":"Notelovitz","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R15-25-20210126","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J Clin Oncol"},{"key":"R16-25-20210126","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2006.10.6179","article-title":"Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.","volume":"26","author":"Goodwin","year":"2008","journal-title":"J Clin Oncol"},{"key":"R17-25-20210126","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0306-4565(92)90018-B","article-title":"Modulation of menopausal hot flashes by ambient temperature.","volume":"17","author":"Kronenberg","year":"1992","journal-title":"J Therm Biol"},{"key":"R18-25-20210126","first-page":"18","article-title":"Use of alternative therapies for menopause symptoms: results of a population-based survey.","volume":"100","author":"Newton","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R19-25-20210126","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/gme.0b013e31816d5b03","article-title":"A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes.","volume":"15","author":"Avis","year":"2008","journal-title":"Menopause"},{"key":"R20-25-20210126","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/01.AOG.0000140688.71638.d3","article-title":"Phytoestrogens for treatment of menopausal symptoms: a systematic review.","volume":"104","author":"Krebs","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R21-25-20210126","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-145-12-200612190-00003","article-title":"Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.","volume":"145","author":"Newton","year":"2006","journal-title":"Ann Intern Med"},{"key":"R22-25-20210126","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.","volume":"16","author":"Barton","year":"1998","journal-title":"J Clin Oncol"},{"key":"R23-25-20210126","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"key":"R24-25-20210126","first-page":"337","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial.","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R25-25-20210126","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1097\/01.AOG.0000245449.97365.97","article-title":"Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.","volume":"108","author":"Soares","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R26-25-20210126","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/gme.0b013e31805170eb","article-title":"The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R28-25-20210126","first-page":"215","article-title":"Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.","volume":"84","author":"Handa","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R29-25-20210126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-9378(96)70378-2","article-title":"A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.","volume":"174","author":"Henriksson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R30-25-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"key":"R31-25-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/cmt.5.2.151.155","article-title":"Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.","volume":"5","author":"Dew","year":"2002","journal-title":"Climacteric"},{"key":"R32-25-20210126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R33-25-20210126","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.293.8.935","article-title":"Effects of estrogen with and without progestin on urinary incontinence.","volume":"293","author":"Hendrix","year":"2005","journal-title":"JAMA"},{"key":"R34-25-20210126","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","article-title":"A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.","volume":"180","author":"Eriksen","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R35-25-20210126","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: Replens versus local estrogen in menopausal women.","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertil Steril"},{"key":"R37-25-20210126","article-title":"Assessment of osteoporosis at the primary health care level: summary report of a WHO Scientific Group.","year":"2007"},{"key":"R38-25-20210126","article-title":"Clinician's guide to prevention and treatment of osteoporosis. 2nd ed.","year":"2008"},{"key":"R39-25-20210126","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1359\/jbmr.090402","article-title":"Perspective: FRAX facts.","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Min Res"},{"key":"R40-25-20210126","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: the United States perspective.","volume":"19","author":"Tosteson","year":"2008","journal-title":"Osteoporosis Int"},{"key":"R41-25-20210126","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1210\/jcem.86.12.8079","article-title":"Timing of estrogen replacement therapy for optimal osteoporosis prevention.","volume":"86","author":"Cauley","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-25-20210126","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density.","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"R43-25-20210126","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultralow-dose micronized 17\u03b2-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.","volume":"290","author":"Prestwood","year":"2003","journal-title":"JAMA"},{"key":"R44-25-20210126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R45-25-20210126","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.AOG.0000114986.14806.37","article-title":"Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.","volume":"104","author":"Yates","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R46-25-20210126","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"R47-25-20210126","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"R48-25-20210126","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"R49-25-20210126","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women.","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"R50-25-20210126","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"R51-25-20210126","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett-Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"R52-25-20210126","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"R53-25-20210126","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"R54-25-20210126","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM199109123251102","article-title":"Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study.","volume":"325","author":"Stampfer","year":"1991","journal-title":"N Engl J Med"},{"key":"R55-25-20210126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"R56-25-20210126","doi-asserted-by":"crossref","first-page":"455","DOI":"10.7326\/0003-4819-115-6-455","article-title":"Postmenopausal estrogen and prevention bias.","volume":"115","author":"Barrett-Connor","year":"1991","journal-title":"Ann Intern Med"},{"key":"R57-25-20210126","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"R58-25-20210126","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group.","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"R59-25-20210126","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/j.1471-0528.2002.01544.x","article-title":"A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study.","volume":"109","author":"Clarke","year":"2002","journal-title":"Br J Obstet Gynaecol"},{"key":"R60-25-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500042417","article-title":"KEEPS: the Kronos Early Estrogen Prevention Study.","volume":"8","author":"Harman","year":"2005","journal-title":"Climacteric"},{"key":"R61-25-20210126","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/aje\/kwm213","article-title":"Invited commentary: hormone therapy and risk of coronary heart disease\u2014why renew the focus on the early years of menopause?","volume":"166","author":"Manson","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R62-25-20210126","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification.","volume":"356","author":"Manson","year":"2007","journal-title":"N Engl J Med"},{"key":"R63-25-20210126","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestins\u2014the ESTHER study.","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"key":"R64-25-20210126","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"R65-25-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM200007063430103","article-title":"Primary prevention of coronary heart disease in women through diet and lifestyle.","volume":"343","author":"Stampfer","year":"2000","journal-title":"N Engl J Med"},{"key":"R66-25-20210126","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics.","volume":"49","author":"Parkin","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"R67-25-20210126","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","article-title":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"R68-25-20210126","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/jama.283.4.485","article-title":"Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk.","volume":"283","author":"Schairer","year":"2000","journal-title":"JAMA"},{"key":"R69-25-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","article-title":"Unopposed estrogen therapy and the risk of invasive breast cancer.","volume":"166","author":"Chen","year":"2006","journal-title":"Arch Intern Med"},{"key":"R70-25-20210126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study.","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"R71-25-20210126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","article-title":"HABITS (hormonal replacement therapy after breast cancer\u2014is it safe?), a randomised comparison: trial stopped.","volume":"363","author":"Holmberg","year":"2004","journal-title":"Lancet"},{"key":"R72-25-20210126","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"R73-25-20210126","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1001\/jama.290.13.1739","article-title":"Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial.","volume":"290","author":"Anderson","year":"2003","journal-title":"JAMA"},{"key":"R74-25-20210126","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0002-9378(96)70027-3","article-title":"Estrogen replacement in surgical stage I and II endometrial cancer survivors.","volume":"175","author":"Chapman","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R75-25-20210126","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jama.2009.1052","article-title":"Hormone therapy and ovarian cancer.","volume":"302","author":"M\u00f8rch","year":"2009","journal-title":"JAMA"},{"issue":"suppl 4","key":"R76-25-20210126","first-page":"S1","article-title":"Hormone therapy.","volume":"104","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R77-25-20210126","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1001\/jama.279.9.688","article-title":"Estrogen therapy in postmenopausal women: effects on cognitive function and dementia.","volume":"279","author":"Yaffe","year":"1998","journal-title":"JAMA"},{"key":"R78-25-20210126","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study\u2014a randomized controlled trial.","volume":"289","author":"Shumaker","year":"2003","journal-title":"JAMA"},{"key":"R79-25-20210126","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.","volume":"291","author":"Espeland","year":"2004","journal-title":"JAMA"},{"key":"R80-25-20210126","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/cmt.4.3.243.249","article-title":"Longitudinal study of hormone levels and depression among women transitioning through menopause.","volume":"4","author":"Avis","year":"2001","journal-title":"Climacteric"},{"key":"R81-25-20210126","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.58.6.529","article-title":"Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.","volume":"58","author":"Soares","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R82-25-20210126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0306-4530(96)00034-0","article-title":"A meta-analysis of the effect of hormone replacement therapy upon depressed mood.","volume":"22","author":"Zweifel","year":"1997","journal-title":"Psychoneuroendocrinology"},{"key":"R83-25-20210126","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/gme.0b013e31817b076a","article-title":"Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.","volume":"15","author":"Utian","year":"2008","journal-title":"Menopause"},{"key":"R84-25-20210126","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding.","volume":"75","author":"Archer","year":"2001","journal-title":"Fertil Steril"},{"key":"R85-25-20210126","first-page":"693","article-title":"Cyclic hormone replacement therapy using quarterly progestin.","volume":"83","author":"Ettinger","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R86-25-20210126","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0015-0282(01)02846-1","article-title":"A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.","volume":"76","author":"Varila","year":"2001","journal-title":"Fertil Steril"},{"key":"R87-25-20210126","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/gme.0b013e31803867a","article-title":"A randomized, open label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women.","volume":"14","author":"Shifren","year":"2007","journal-title":"Menopause"},{"key":"R88-25-20210126","first-page":"1233","article-title":"Predictors of difficulty when discontinuing postmenopausal hormone therapy.","volume":"102","author":"Grady","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R89-25-20210126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/gme.0b013e31818fbff5","article-title":"Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?","volume":"16","author":"Haskell","year":"2009","journal-title":"Menopause"},{"key":"R90-25-20210126","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the Nurses' Health Study.","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R91-25-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy.","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause"},{"key":"R92-25-20210126","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"key":"R93-25-20210126","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1210\/jc.2008-1272","article-title":"Approach to the patient with menopausal symptoms.","volume":"93","author":"Martin","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0b013e3181d41191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:16Z","timestamp":1786040116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201004000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181d41191","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}